Author:
Schroeder Wolfgang,Ghadimi Markus P. H.,Schloesser Hans,Loeser Heike,Schiller Petra,Zander Thomas,Gebauer Florian,Fuchs Hans,Quaas Alexander,Bruns Christiane J.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Lordick F, Mariette C, Haustermans K, et al. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v50–7.
2. Porschen R, Fischbach W, Gockel I, et al. S3-Leitlinie – diagnostik und therapie der plattenepithelkarzinome und adenokarzinome des ösophagus. Z Gastroenterol. 2019;57:336–418.
3. Ajani JA, D’Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17:855–83.
4. Ronellenfitsch U, Schwarzbach M, Hofheinz R, et al. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus. Cochrane Database Syst Rev. 2013;31:CD008107.
5. Shapiro J, van Lanschot JJB, Hulshof M, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16:1090–8.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献